Sovihep V (Sofosbuvir Velpatasvir)
Sovihep V - the newest drug for the treatment of hepatitis C 1, 2, 3, 4, 5, 6 genotypes, including in its chronic form and with a complication in the form of cirrhosis of the liver. The tablets contain a combination of active substances - Sofosbuvir and Velpatasvir. This combination has a detrimental effect on the hepatitis virus and does not require additional drugs.
Buy Sovihep V recommended for treatment of any of the 6 genotype of the virus C. The drug is a generic of the original means and is available in India. It completely repeats the composition of the original and contains Sofosbuvir and Velpatasvir. The drug is indicated in the treatment of protracted forms of hepatitis C, as well as in the presence of a concomitant disease - liver cirrhosis.
The effectiveness of the funds due to the impact on 2 proteins that are necessary for the virus to grow and multiply. Proteins are inhibited, and the hepatitis virus does not spread in the blood, its growth stops. In some cases, ribavirin is additionally taken, which contributes to the speedy recovery in the presence of cirrhosis of the liver. Sovihep V avoids complications and strong effects on the liver.
Studies have been conducted regarding the effectiveness of the drug. It was found that patients suffering from hepatitis C of the 1st and 2nd genotype recover in 100% of cases, the 3rd genotype - 98%, 4th, 5th and 6th - 98-100%. The last 3 genotypes are practically not found in our country.
INDICATIONS FOR USE
Buy Sofosbuvir and Velpatasvir is necessary for the treatment of hepatitis C 1-6 genotype, as well as its chronic form. Cirrhosis does not interfere with therapy.
FORM OF ISSUE
The price of Sovihep V corresponds to the product packaging, which contains 28 coated oval tablets. Each contains 400 mg of Sofosbuvir and 100 mg of Velpatasvir. Knowing how long the treatment will take, you can calculate the price of Sofosbuvir and Velpatasvir. The standard course is 12 weeks, so you will need 3 packs of the drug.
METHOD OF ADMINISTRATION AND DOSES
Sovihep V is taken on a daily basis at the same time. Eating does not affect the effectiveness of the tool. The tablet is not crushed and crushed, because it contains the optimal treatment dose for Sofosbuvir and Velpatasvir. It is important to comply with the dosage and avoid receiving double servings.
Before treatment, the patient passes all tests and in particular for viral load. After 4 weeks of admission, the doctor must check whether the therapy helps to get rid of the virus. This is important because the patient himself needs to tune in for recovery. This is especially important for those who have already received treatment with other drugs, and this did not bring a positive result. Do not stop taking Sovihep V until the end of the 12-week course. This can lead to the formation of hepatitis C virus resistance to Sofosbuvir.
If within 2 hours after taking the drug, vomiting began, you need to swallow another pill. After 3 hours, the active substances are already absorbed. Therefore, in the presence of vomiting during this period, there is no need for re-admission. If the tablet has not been used on time, it is necessary to do it within 18 hours and take the next according to the instructions.
Unpleasant symptoms rarely occur after taking Sovihep V . Mild headache, dizziness, nausea, diarrhea, fatigue and pain in the joints. All side effects must be reported to your doctor.
CONTRAINDICATIONS FOR USE
Component allergy or individual intolerance
INTERACTION WITH OTHER PREPARATIONS
The effectiveness of Sofosbuvir is reduced when taken simultaneously with rifampicin.
In the reach of children at a temperature of up to 30 degrees Celsius.
- Trade name Sovihep V
- Substance Sofosbuvir 400 mg Velpatasvir 100mg
- Manufacturer Zydus Heptiza
- Packaging 28 tablets
- Country of origin India
Velpatasvir is an active substance recently synthesized, which aims to eliminate the hepatitis C virus of all six genotypes. Original instruction velpatasvira Сhina.
Sofosbuvir is a pangenotypic inhibitor of the RNA-dependent NS5B RNA polymerase of the hepatitis C virus (HCV) required for viral replication. Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form a pharmacologically active uridine triphosphate analogue (GS-461203).